AI in Drug Development: From Discovery to Strategic Advantage

AI is moving beyond experimental applications to become a strategic layer across the drug development lifecycle. In this edition of the Octavus Insights Corner, we examine how Artificial Intelligence is reshaping drug development - from target identification and molecule design to preclinical research, clinical development, regulatory evidence, and post-market safety. What this report covers • The AI foundation of modern drug development • How AI is being applied across the drug development lifecycle • AI-powered target discovery and molecule design • AI in preclinical safety and ADMET prediction • AI-enabled clinical trial design and patient selection • AI-assisted regulatory evidence and governance • FDA, EMA and evolving AI regulatory expectations • AI drug development market growth and competitive dynamics • Investment activity across AI-enabled drug development • Emerging technologies including generative AI, biological foundation models, quantum computing and laboratory automation • Rentosertib as an example of an end-to-end AI-enabled drug development journey • Competitive capabilities and strategic implications • The future of AI, automation and human expertise in drug development Key takeaway The next phase of AI adoption in drug development will increasingly depend not only on model performance, but on data quality, validation, clinical translation, regulatory readiness and the ability to integrate AI into real-world development workflows. About Octavus Consulting Octavus Consulting is a healthcare intelligence and strategic research firm supporting life sciences decision-makers with competitive intelligence, market research, clinical pipeline intelligence, due diligence, market access, commercial strategy, and other research-led solutions. 📩 bd@octavusconsulting.com 🌐 www.octavusconsulting.com Subscribe to Octavus Consulting for more healthcare intelligence, pharmaceutical industry analysis, competitive intelligence, and strategic insights. #AIinDrugDevelopment #DrugDiscovery #PharmaAI #ArtificialIntelligence #DrugDevelopment #HealthcareAI #PharmaceuticalIndustry #LifeSciences #ClinicalTrials #OctavusConsulting